Table: begin end state 1 28 cytoplasmic 29 50 transmembrane 51 59 non-cytoplasmic 60 81 transmembrane 82 99 cytoplasmic 100 125 transmembrane 126 157 non-cytoplasmic 158 177 transmembrane 178 184 cytoplasmic 185 207 transmembrane 208 218 non-cytoplasmic 219 238 transmembrane 239 258 cytoplasmic 259 284 transmembrane 285 304 non-cytoplasmic 305 333 transmembrane 334 355 cytoplasmic 356 375 transmembrane 376 380 non-cytoplasmic 381 400 transmembrane 401 411 cytoplasmic 412 432 transmembrane 433 437 non-cytoplasmic 438 457 transmembrane 458 465 cytoplasmic
Input: >WP_041675872.1 NCBI__GCF_000021545.1:WP_041675872.1 MQEVSVKDFFRKRYYDGIKDTKLKRSLGLWDLVFIGVGGIIGAGIFVITGQAAAAYAGPG IILSFVLSAIAIGITALVYAEFSSAFPISGSAYSYTYATLGEVIAWLVAWNILLEYGVAA AAVATGWSGYLRTFLENNFGFTLPVALSGAFDPSKGTVIDLFAFLGMAGVFALLTIGIKE SARVNFFIVLLKLAVLLVFIFIGLKYVKLENITSNFLPYGWQGVWSAASLIVFAYLGFDA VSTLAEETKDPQKTLPKGLILSLSISTVLYITVSFVLVGILPYYSYEGKPDSLAYAMYQV NEKWVADFISLGAVITITSVMIVMGLGFTRVLYSLARDRLFFKTFADIHPKFNTPYKASI LGGVFLSVLAGFLPLKILAEMVNIGTLFAYFMVGVAAIVIKNRPDIRPIFKVPYPNLLLP LNLIFLMFIMAGLPFDTWMRFFIWTIIGILIYFFYGYKNSILGKS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server